These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 36341995)
1. Use of Artificial Intelligence for the Interpretable Prediction of the Pathologic Diagnosis and Molecular Abnormalities of Flat Urothelial Lesions. Nishikawa T; Matsuzaki I; Ryuta I; Musangile FY; Sagan K; Nishikawa M; Mikasa Y; Takahashi Y; Kojima F; Murata SI Am J Pathol; 2023 Jan; 193(1):39-50. PubMed ID: 36341995 [TBL] [Abstract][Full Text] [Related]
2. A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from Digitized Urine Cytology Slides Using Deep Learning. Tsuji K; Kaneko M; Harada Y; Fujihara A; Ueno K; Nakanishi M; Konishi E; Takamatsu T; Horiguchi G; Teramukai S; Ito-Ihara T; Ukimura O Eur Urol Oncol; 2024 Apr; 7(2):258-265. PubMed ID: 38065702 [TBL] [Abstract][Full Text] [Related]
3. Targeted Next-Generation Sequencing of Flat Urothelial Lesions Reveals Putative Pathobiological Pathways, Potential Biomarkers, and Rational Therapeutic Targets. Musangile FY; Matsuzaki I; Iwamoto R; Sagan K; Nishikawa M; Mikasa Y; Takahashi Y; Kojima F; Hara I; Murata SI Mod Pathol; 2023 May; 36(5):100120. PubMed ID: 36812689 [TBL] [Abstract][Full Text] [Related]
5. [Pathologic diagnosis and management of flat lesions of urothelium detected with aminolevulinic acid (Hexvix®)]. Compérat E; Conort P; Rouprêt M; Camparo P; Mazerolles C Prog Urol; 2011 Mar; 21(3):157-65. PubMed ID: 21354032 [TBL] [Abstract][Full Text] [Related]
6. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions]. Sibony M; Billerey C Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498 [TBL] [Abstract][Full Text] [Related]
7. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions. Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577 [TBL] [Abstract][Full Text] [Related]
8. Urothelial dysplasia of the bladder: diagnostic features and clinical significance. Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498 [TBL] [Abstract][Full Text] [Related]
9. Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair. Blanes A; Rubio J; Sanchez-Carrillo JJ; Diaz-Cano SJ Hum Pathol; 2009 Jul; 40(7):988-97. PubMed ID: 19368958 [TBL] [Abstract][Full Text] [Related]
10. [Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions]. Helpap B; Köllermann J Pathologe; 2000 May; 21(3):211-7. PubMed ID: 10900613 [TBL] [Abstract][Full Text] [Related]
11. Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice. Paner GP; Smith SC; Hartmann A; Agarwal PK; Compérat E; Amin MB Mod Pathol; 2022 Oct; 35(10):1296-1305. PubMed ID: 35468997 [TBL] [Abstract][Full Text] [Related]
12. Pathologic Image Classification of Flat Urothelial Lesions Using Pathologic Criteria-Based Deep Learning. Nishikawa T; Iwamoto R; Matsuzaki I; Musangile FY; Takahashi A; Mikasa Y; Takahashi Y; Kojima F; Murata SI Am J Clin Pathol; 2022 Dec; 158(6):759-769. PubMed ID: 36197883 [TBL] [Abstract][Full Text] [Related]
13. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. McKenney JK; Gomez JA; Desai S; Lee MW; Amin MB Am J Surg Pathol; 2001 Mar; 25(3):356-62. PubMed ID: 11224606 [TBL] [Abstract][Full Text] [Related]
14. Urothelial carcinoma in situ: diagnostic update. McKenney JK Pathology; 2021 Jan; 53(1):86-95. PubMed ID: 33234229 [TBL] [Abstract][Full Text] [Related]
15. Bladder Tumor Subtype Commitment Occurs in Carcinoma Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889 [TBL] [Abstract][Full Text] [Related]
16. Lewis(y) antigen (blood group 8, BG8) is a useful marker in the histopathological differential diagnosis of flat urothelial lesions of the urinary bladder. Gunia S; Kakies C; May M; Koch S; Erbersdobler A J Clin Pathol; 2011 Aug; 64(8):672-6. PubMed ID: 21512109 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Guo CC; Fine SW; Epstein JI Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332 [TBL] [Abstract][Full Text] [Related]
19. Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies. Montironi R; Lopez-Beltran A; Mazzucchelli R; Bostwick DG J Clin Pathol; 2003 Feb; 56(2):91-5. PubMed ID: 12560385 [TBL] [Abstract][Full Text] [Related]
20. Could double stain for p53/CK20 be a useful diagnostic tool for the appropriate classification of flat urothelial lesions? Di Sciascio L; Ambrosi F; Franceschini T; Giunchi F; Franchini E; Massari F; Bianchi FM; Colecchia M; Fiorentino M; Ricci C Pathol Res Pract; 2022 Jun; 234():153937. PubMed ID: 35561522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]